News
Over the Last 25 Years, Latanoprost Has Changed the Paradigm of Glaucoma Treatment
An important milestone in the treatment of glaucoma was the introduction of latanoprost with an entirely new mechanism of action compared to previously used antiglaucoma medications. Prostaglandin analogs (PGAs) have become the first-line treatment for primary open-angle glaucoma (POAG) primarily due to their efficacy, once-daily dosing, and minimal systemic side effects. The following recent review briefly summarizes the impact of the introduction of PGAs 25 years ago on current clinical practice in the treatment of glaucoma.
New Technology Teaches Healthcare Professionals to Deliver Messages Patients Don't Want to Hear
Communication with patients and their relatives is often very challenging for doctors and nurses,…
EAHAD 2024: Fresh results of paradigm5 and 6 studies confirm safety and efficacy of N9-GP
Nonacog beta pegol (N9-GP) is a recombinant factor IX with an extended half-life. Its properties…
What is the future of xenotransplantation? Pig liver and kidneys transplanted to humans for the first time
The initial successes of pig organ transplants to humans, conducted this March, gave hope that…
Updated Recommendations of the European Society of Cardiology for the Treatment of HCM
Newly published guidelines by the European Society of Cardiology (ESC) bring several updates in the…
Ultrasound in a Patch – Smart System Capable of Monitoring Patient During Regular Activities
A team of scientists from the University of California, San Diego, has developed a miniature…
Comparison of 5 Beta-Blockers in Heart Failure with Reduced Ejection Fraction
An analysis of 26 studies with beta-blockers in the treatment of heart failure with reduced…
Interactive Case Study: Treatment of Neuropathic Pain in a Patient with Neurodegenerative Disease
We offer a brief case study of a polymorbid patient suffering from chronic pain, spasticity, and sleep...
Long-term Benefit of Luspatercept Therapy – Fresh Data from the MEDALIST Study
The goal of therapy for low-risk myelodysplastic syndrome (MDS) is to compensate for anemia,…
Use of Medical Cannabis in Patients with Fibromyalgia to Relieve Pain and Depression
Medical cannabis is prescribed to patients with chronic pain resistant to conventional treatments.…